ARCHIVES

NCI Cooperative Group, Cancer Center Trials Listed

This article is from The Cancer Letter archive.

Vol. 31 No. 3 | March 28, 2008

Download PDF Visit The Full Archive

Related Articles

Markison leaving Bristol-Myers, two others promoted in reorganization.

January 30, 2004

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

ASCO Writes A New Mission Statement Placing Emphasis On Helping Patients

May 21, 1999

Frozen Section Analysis Helps Avoid Second Surgery

September 30, 2005

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

July 22, 2011

Bill Clinton Endorses NBCC’s 2020 Goal

January 14, 2011